CBFB and acute myeloid leukemia: For CBFB-MYH11 AMLs, fusion breakpoint location21 nearly reached significance in prediction of EFS within our training cohort (Supplementary Fig. 11) and reached significance within our previously published results when the CBFB-MYH11 AML cohort was analyzed in aggregate43.